Government funding bill deal will repeal key ACA taxes

• If this wasn't good enough news for the industry, the deal won't address surprise medical bills — and it avoids prescription drug prices except for the CREATES Act, which helps generics get to market faster.
• The taxes have been repeatedly delayed. And while the industry has pushed for their repeal for years, it hasn't yet been successful.

Between the lines: Voters are decidedly not asking Washington to lift industry taxes while avoiding dealing with two of the most popular health care issues, but if that's how this plays out, it's a great indicator that the industry's lobbying strength is as good as ever.

• It's also a good sign that cost control — the intention of the Cadillac tax, a 40% excise tax on the most generous employer plans — is still not very popular with lawmakers, even as health care costs continue to rise.

• The tax was expected to raise $200 billion over 10 years.

The other side: The industry says that the ACA taxes end up getting passed along to patients.

Go deeper:

• The Affordable Care Act's free health plans
• SCOTUS seems to side with insurers in ACA risk corridor case
• The return of the ACA wars